ERBITUX CETUXIMAB & SHORT ANTIBODY DESIGN

View On IC.GC.CA

REGISTERED

on 9 Jan 2008

Last Applicant/ Owned by

IMCLONE LLC

450 East 29th StreetNew York, New York 10016

Serial Number

1168503 filed on 19^th Feb 2003

Registration Number

TMA704238 registered on 9^th Jan 2008

Registration expiry Date

9^th Jan 2033

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

K1P1J9

ERBITUX CETUXIMAB & SHORT ANTIBODY DESIGN

Trademark usage description

pharmaceutical preparation, namely monoclonal antibody for the treatment of cancer.

Vienna Information

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

Classification Information

Class [005]
Pharmaceutical preparation, namely monoclonal antibody for the treatment of cancer.

Classification kind code

Mark Details

Serial Number

1168503

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 51 on 22^nd Dec 2006	Allowance Notice Sent
Submitted for opposition 71 on 19^th Dec 2006	Opposition Removed
Submitted for opposition 70 on 19^th Feb 2004	Opposed
Submitted for opposition 42 on 17^th Dec 2003	Advertised
Submitted for opposition 15 on 4^th Dec 2003	Correspondence Created
Submitted for opposition 26 on 12^th Nov 2003	Approved
Submitted for opposition 22 on 10^th Nov 2003	Search Recorded
Submitted for opposition 31 on 4^th Mar 2003	Formalized
Submitted for opposition 1 on 24^th Feb 2003	Created
Submitted for opposition 30 on 19^th Feb 2003	Filed

ERBITUX CETUXIMAB & SHORT ANTIBODY DESIGN

Classification Information

Class [005]Pharmaceutical preparation, namely monoclonal antibody for the treatment of cancer.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparation, namely monoclonal antibody for the treatment of cancer.